Asset Management One Co. Ltd. grew its position in Ventas, Inc. (NYSE:VTR – Free Report) by 0.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 924,800 shares of the real estate investment trust’s stock after purchasing an additional 6,233 shares during the period. Asset Management One Co. Ltd. owned approximately 0.20% of Ventas worth $73,652,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. NewEdge Advisors LLC grew its position in Ventas by 856.1% during the 1st quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock worth $545,000 after purchasing an additional 7,097 shares in the last quarter. Empowered Funds LLC grew its stake in Ventas by 6.8% in the 1st quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock valued at $576,000 after buying an additional 536 shares during the last quarter. Woodline Partners LP grew its position in Ventas by 46.8% in the 1st quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock worth $2,532,000 after purchasing an additional 11,739 shares during the last quarter. Focus Partners Wealth boosted its position in shares of Ventas by 130.4% during the 1st quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock valued at $1,486,000 after acquiring an additional 12,233 shares in the last quarter. Finally, Gamco Investors INC. ET AL acquired a new stake in shares of Ventas during the 2nd quarter valued at about $805,000. 94.18% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In related news, CEO Debra A. Cafaro sold 10,322 shares of the business’s stock in a transaction dated Monday, February 2nd. The stock was sold at an average price of $77.66, for a total value of $801,606.52. Following the sale, the chief executive officer directly owned 1,114,034 shares in the company, valued at approximately $86,515,880.44. The trade was a 0.92% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Carey S. Roberts sold 35,532 shares of the company’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $85.00, for a total value of $3,020,220.00. Following the sale, the executive vice president owned 72,755 shares in the company, valued at approximately $6,184,175. This represents a 32.81% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 0.53% of the company’s stock.
Ventas Stock Down 0.5%
Ventas (NYSE:VTR – Get Free Report) last released its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.89 by ($0.74). The company had revenue of ($1,229.71) million during the quarter, compared to the consensus estimate of $1.53 billion. Ventas had a net margin of 4.31% and a return on equity of 2.09%. The business’s revenue was up 21.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.81 EPS. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Equities analysts predict that Ventas, Inc. will post 3.4 EPS for the current year.
Ventas Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st were paid a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date was Tuesday, March 31st. This is a positive change from Ventas’s previous quarterly dividend of $0.48. Ventas’s dividend payout ratio (DPR) is presently 385.19%.
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on VTR. Morgan Stanley set a $90.00 price target on shares of Ventas in a report on Friday, February 13th. Wells Fargo & Company upped their price target on shares of Ventas from $88.00 to $93.00 and gave the company an “overweight” rating in a report on Thursday, March 26th. Mizuho increased their target price on shares of Ventas from $87.00 to $94.00 and gave the stock an “outperform” rating in a report on Wednesday, March 4th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $93.00 price target on shares of Ventas in a research report on Monday, February 9th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Ventas from $88.00 to $93.00 and gave the company an “overweight” rating in a research report on Friday, March 20th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $90.47.
Get Our Latest Stock Analysis on Ventas
About Ventas
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Featured Stories
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
